Created in 2002, Generis® quickly became a leading company in Portugal in the generic drug market. In 2006, the company acquired its first manufacturing facility, with the aim of implementing a solid and sustained growth strategy. Today, Generis® is part of the Aurobindo Group, present in more than 20 countries, vertically integrated from R&D to marketing. The Group holds 26 factories with the latest equipment and exports to more than 150 countries.
Generis® has a comprehensive portfolio, with coverage greater than 85% of the therapeutic areas, where the most relevant are part of the outpatient market. Consisting of 1,492 prescription medicines, 254 products for hospital use and 67 OTC / Health Products, the Generis® portfolio allows to satisfy an increasing number of patients, with high quality therapeutic solutions at an affordable cost.